Latest News about AFIB

Recent news which mentions AFIB

< Previous 1 2 3 4 5 Next >

Stocks That Hit 52-Week Lows On Monday

January 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022

January 20, 2022

Acutus Medical Plans Job Cuts; Preliminary Q4, FY21 Sales Exceed Estimates

January 19, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

January 14, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 14, 2022

January 14, 2022

Rhythm Therapeutics rebrands as Inomagen Therapeutics

December 01, 2021

Overview Of Value Stocks In The Healthcare Sector

November 29, 2021

12 Health Care Stocks Moving In Wednesday's After-Market Session

November 24, 2021

70 Biggest Movers From Friday

November 15, 2021

Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop

November 12, 2021

Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet

November 12, 2021

48 Stocks Moving In Friday's Mid-Day Session

November 12, 2021

Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter

November 12, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 12, 2021

November 12, 2021

The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares

November 12, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

November 12, 2021

Acutus Medical, Inc. (AFIB) Q3 2021 Earnings Call Transcript

November 12, 2021

Recap: Acutus Medical Q3 Earnings

November 11, 2021

Earnings Scheduled For November 11, 2021

November 11, 2021

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

October 12, 2021

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

October 08, 2021

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

October 07, 2021

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

October 06, 2021

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

October 05, 2021

Acutus Medical's Return On Capital Employed Overview

September 30, 2021

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive

September 28, 2021

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data

September 23, 2021

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs

September 22, 2021

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

September 21, 2021

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

September 16, 2021

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.